Post-authorisation Study of Biological Relapse in Patients With Multiple Myeloma

Clinical trial NCT02394210 · TERMINATED

Trial details

NCT number: NCT02394210
Sponsor: Celgene
Status: TERMINATED
Study type: OBSERVATIONAL

Multiple Myeloma

Start date: 2013-05-14
Primary completion: 2021-05-18
Enrollment: 415

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.